“Pioneering RNA editing technology as an alternative to DNA editing for treating rare genetic disorders”
Joseph Ruiz, President, Enzerna Biosciences, Inc., Chapel Hill, NC
Loading view.
L300 Carrington Hall-Fox Auditorium
Events from this organizer